Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients

NCT00953914 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Complications

Interventions

DRUG: Pyridostigmine
DRUG: Placebo

Sponsor

Hospital de Clinicas de Porto Alegre